Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Eravacycline

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Everest Medicines Announces Commercial Launch and First Prescription for XERAVA
    Everest Medicines Announces Commercial Launch and First Prescription for XERAVA

    26 Jul 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/everest-medicines-announces-commercial-launch-and-first-prescription-for-xerava-in-china-301886863.html

    PR NEWSWIRE
    26 Jul 2023
    Share Share
    Everest Medicines Announces Approval of Xerava in China
    Everest Medicines Announces Approval of Xerava in China

    17 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/everest-medicines-announces-approval-of-xerava-in-china-for-the-treatment-of-complicated-intra-abdominal-infections-in-adult-patients-301774097.html

    PR NEWSWIRE
    17 Mar 2023
    Share Share
    La Jolla Announces Data on XERAVA to be Presented at IDWeek 2022
    La Jolla Announces Data on XERAVA to be Presented at IDWeek 2022

    14 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221014005417/en

    BUSINESSWIRE
    14 Oct 2022
    Share Share
    Everest Medicines Announces Approval of XERAVA in Hong Kong
    Everest Medicines Announces Approval of XERAVA in Hong Kong

    07 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/everest-medicines-announces-approval-of-xerava-in-hong-kong-for-the-treatment-of-complicated-intra-abdominal-infections-301643527.html

    PRNEWSWIRE
    07 Oct 2022
    Share Share
    Everest Medicines gets China NMPA approval to begin phase 3 trial of Xeravam
    Everest Medicines gets China NMPA approval to begin phase 3 trial of Xeravam

    06 Aug 2021

    // PHARMABIZ

    http://www.pharmabiz.com/ArticleDetails.aspx?aid=140617&sid=2

    PHARMABIZ
    06 Aug 2021
    Share Share
    La Jolla Company Announces Exclusive Licensing Agreement for GIAPREZA™
    La Jolla Company Announces Exclusive Licensing Agreement for GIAPREZA™

    12 Jan 2021

    // NASDAQ

    https://www.nasdaq.com/press-release/la-jolla-pharmaceutical-company-announces-exclusive-licensing-agreement-for

    NASDAQ
    12 Jan 2021
    Share Share